WIPO trademark

SIRELIS

MixedWIPOClass 40Class 42

"SIRELIS" is a trademark owned by Alnylam Pharmaceuticals, Inc., filed at the WIPO on January 26, 2026. It is on file and covers classes 40 and 42.

SIRELIS
Trademark as filed with the WIPO
Status
Mixed
Filed
January 26, 2026
Registered
Not yet
Expires
January 26, 2036
Application no.
Not recorded
Registration no.
1906873
Office
WIPO
World Intellectual Property Organization
Mark type
Trademark
2 classes
Ownership

Who owns SIRELIS

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Goods and services

What the mark covers

The products and services SIRELIS is filed for, grouped by Nice class.

  • Providing technical information in the field of pharmaceutical manufacturing; manufacturing services for others in the field of sirna synthesis; custom manufacture of sirna therapeutics; custom manufacture of rna utilizing proprietary enzymatic technologies to enable nucleic acid therapeutics development.

  • Scientific research and development; research and development of small molecule RNA drugs; research and development of siRNA drugs; RNA interference technology research.

FAQ

About SIRELIS

Who owns the trademark "SIRELIS"?

The WIPO trademark "SIRELIS" is owned by Alnylam Pharmaceuticals, Inc.

What is the status of "SIRELIS"?

Its status at the WIPO is: mixed.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull SIRELIS and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

GET /v1/trademarks/{id}
ID=tm_ced84021-423e-4296-8109-29a1b1e9e3f6
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_ced84021-423e-4296-8109-29a1b1e9e3f6",
  "object": "trademark",
  "mark_text": "SIRELIS",
  "status": {
    "primary": "mixed",
    "stage": "mixed"
  },
  "office_code": "WO",
  "application_number": null,
  "filing_date": "2026-01-26",
  "nice_classes": [
    40,
    42
  ],
  "owners": [
    {
      "name": "Alnylam Pharmaceuticals, Inc.",
      "entity_id": "ent_019eb709-7d9a-70dc-b19d-2c56e8a223b5"
    }
  ]
}